Smart science to improve lives™
0

Where injectable complexity meets greater confidence.

Croda Pharma helps pharmaceutical teams advance complex injectable development with greater confidence, combining High Purity and Super Refined™ excipient technologies with specialist formulation expertise and regulatory support. From stability and impurity control to scale-up, Croda helps you move forward with confidence. Explore our offering for:

Small molecule injectables
Large molecule injectables
Peptide injectables

Complex injectable formulations demand confidence at every stage

Injectable dosage forms can offer important advantages, from predictable absorption to the elimination of first-pass metabolism. But those advantages come with formulation challenges. Drug stability, solubility, API compatibility, impurity control, excipient quality, regulatory expectations and scale-up confidence can all influence how an injectable formulation performs.

Croda Pharma brings together high purity excipient technologies, Super Refined™ purification, specialist formulation knowledge and regulatory support to help pharmaceutical teams make more confident decisions across complex injectable development.

High purity and Super Refined™ excipient technologies

In injectable formulations, excipient selection is critical to drug stability, formulation integrity and patient safety. Croda Pharma offers High Purity and Super Refined™ excipient technologies designed to support demanding pharmaceutical applications, including parenteral and injectable dosage forms.
 
Super Refined™ excipients use Croda’s proprietary purification technology to reduce oxidative impurities such as peroxides, aldehydes and catalyst residues. This can help minimise API-excipient interactions, support API stability and reduce degradation risks that may affect formulation performance over time.

Supporting formulation performance, drug product value and regulatory confidence

Complex injectable development is not only about creating a viable formulation. It is about protecting the value, quality and performance of the final drug product. Croda’s high purity excipient technologies can help support API stability, oxidative stability, impurity control, formulation shelf life and performance consistency.

For teams navigating quality and regulatory scrutiny, Croda also provides multi-compendial excipient options, documentation support and technical understanding around impurity-related risks, including nitrosamine risk considerations. Together, this helps connect excipient quality, formulation performance and regulatory readiness in one clearer development story.

More than an excipient supplier

Complex injectable development takes more than ingredients alone. It takes science, quality, technical support and supply confidence working together. Croda Pharma works with pharmaceutical teams to support formulation decisions, troubleshoot development challenges and identify excipient solutions for demanding injectable applications.

With specialist formulation knowledge, high purity excipient technologies, regulatory expertise and global capability, Croda brings the support needed to help move complex injectable formulations from challenge towards delivery.